Hematology, Medical Oncology, Oncology/Hematology (Cancer and Blood Disorders)
Accepting New Patients
Practice Philosophy: I emphasize compassion and respect as I educate and guide patients through the treatment process.
Professional School: University of Washington School of Medicine
Residency: University of Vermont College of Medicine
Fellowship: University of Wisconsin School of Medicine and Public
Special Interests: Dr. Dennie has a special interest in treating patients with hematologic malignancies and caring for patients in the geriatric and underserved populations.
Becker PS, Gooley TA, Green DJ, Burwick N, Kim TY, Kojouri K, Inoue Y, Moore DJ, Nelli E, Dennie T, Bensinger WI. A phase 2 study of bortezomib, cyclophosphamide, pegylated liposomal doxorubicin and dexamethasone for newly diagnosed multiple myeloma. Blood Cancer J. 2016 May 13;6:e422. doi: 10.1038/bcj.2016.31.
Dennie T. Metastatic, her-2 amplified lacrimal gland carcinoma with response to lapatinib treatment. Case Rep Oncol Med. 2015;2015:262357. doi: 10.1155/2015/262357. Epub 2015 Feb 2.
Learn more about ongoing studies and medical research at the MultiCare Institute for Research & Innovation.
Trevor Dennie, MD, is board certified in internal medicine, medical oncology and hematology. He cares for patients who require treatment for a wide range of cancers. His clinical interests are in cancers that affect the blood, bone marrow, and lymph nodes, as well as caring for patients in the geriatric and underserved populations. In his free time, he enjoys hiking, bicycling and viewing movies.
The services Dr. Dennie provides include: